Bone Mineral Density Changes in People with HIV Who had Immediate Switch Versus Deferred Switch from Tenofovir Disoproxil Fumarate-Based Regimens to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Multicenter, Open-Label, Randomized Clinical Trial
Bone Mineral Density Changes in People with HIV Who had Immediate Switch Versus Deferred Switch from Tenofovir Disoproxil Fumarate-Based Regimens to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Multicenter, Open-Label, Randomized Clinical Trial
Tangkai Qi, Meiyan Sun, Renfang Zhang, Jiangrong Wang et al.
Citations
1 citations
Journal
Infectious Diseases and Therapy
Topics
HIV-related health complications and treatments
Field-Weighted Citation Impact (FWCI)
2.25
article
Bone Mineral Density Changes in People with HIV Who had Immediate Switch Versus Deferred Switch from Tenofovir Disoproxil Fumarate-Based Regimens to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Multicenter, Open-Label, Randomized Clinical Trial
Tangkai Qi, Meiyan Sun, Renfang Zhang, Jiangrong Wang, Zhihang Zheng, Luling Wu, Yinzhong Shen, Yang Tang, Jingna Xun, Mei Liu, Junyang Yang, Zongxing Yang, Yueming Shao, Li Liu, Jun Chen, Wei Song, Xinping Yang, Jianjun Sun, Jianhua Yu, Zhenyan Wang, Xicheng Wang, Shuibao Xu, Jie Han
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Infectious Diseases and TherapyVol. 15(1)
Institutions
Southern University of Science and Technology (CN), Shanghai Public Health Clinical Center (CN), Shanghai Pulmonary Hospital (CN), Hangzhou Xixi hospital (CN), Yunnan Provincial Infectious Disease Hospital (CN), Zhejiang University (CN)